Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-02-24
2009-08-04
Low, Christopher S. F. (Department: 1636)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093600, C424S093100, C435S252500, C435S252300, C435S320100, C435S069100, C536S023100, C536S023720
Reexamination Certificate
active
07569219
ABSTRACT:
A recombinant double stranded RNA (dsRNA) phage expresses dsRNA-encoded genes in eukaryote cells. Recombinant dsRNA phage are useful for the expression of dsRNA expression cassettes encoding passenger genes, such as, but not restricted to, vaccine antigens, bioactive proteins, immunoregulatory proteins, antisense RNAs, and catalytic RNAs in eukaryotic cells or tissues. Methods are provided to deliver recombinant dsRNA phage to eukaryotic cells and tissues, either by direct administration, formulated in lipid or polylactide-coglycolide, or by utilizing a bacterial vaccine vector.
REFERENCES:
Poranen, Virus Research, 2004, vol. 101, pp. 93-100.
Mindich et al., J. Bacteriology, 1999, vol. 181, No. 15, pp. 4505-4508.
Mindich, Microbiology and Molecular Biology Reviews, 1999, vol. 63, No. 1, pp. 149-160.
Hibbert Catherine
Low Christopher S. F.
University of Maryland Biotechnology Institute
Whitham Curtis Christofferson & Cook, P.C.
LandOfFree
Recombinant double-stranded RNA phage, and use of the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant double-stranded RNA phage, and use of the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant double-stranded RNA phage, and use of the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4075601